Italia markets closed

FTSE MIB
33.812,44
+41,37(+0,12%)
Dow Jones
40.589,34
+654,27(+1,64%)
Nasdaq
17.357,88
+176,16(+1,03%)
Nikkei 225
37.667,41
-202,10(-0,53%)
Petrolio
76,44
-1,84(-2,35%)
Bitcoin EUR
62.611,29
+893,54(+1,45%)

Ionis Pharmaceuticals, Inc. (0JDI.L)

LSE - LSE Prezzo differito. Valuta in USD.

Aggiungi a watchlist

51,88

-0,26

(-0,50%)

Alla chiusura: 02:33PM BST

Capitalizzazione	7,186B
Beta (mensile su 5 anni)	0,40
Rapporto PE (ttm)	N/D
EPS (ttm)	-0,03
Prossima data utili	01 ago 2024
Rendimento e dividendo (futuro)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day
Positive results from preliminary analysis of PRAX-222 Part 1 showed 44% median reduction in seizures after three doses for SCN2A-gain-of-function pediatric patients Phase 3 (Essential3) program for ulixacaltamide initiating this quarter with mADL11 as primary endpoint; nearly 600 patients have already expressed interest in participating BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insigh